SAN DIEGO: OncoSec Medical, a biotechnology company, hired the Investor Relations Group (IRG) as its PR and IR agency. The company is developing treatments for skin cancer and other cancers. IRG plans to target portfolio managers and equity analysts to raise awareness of OncoSec's treatments, as well conduct a media outreach campaign targeted at relevant national trade and consumer outlets.
Have you registered with us yet?
Register now to enjoy more articles and free email bulletinsRegister
Already registered?Sign in
Join a growing community of PRWeek comms professionals today
- Read more articles each month
- Sign up for free specialised news bulletins